Change search
ReferencesLink to record
Permanent link

Direct link
Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study
Umeå University, Faculty of Medicine, Department of Radiation Sciences, Oncology.
Show others and affiliations
2013 (English)In: Breast Cancer Research, ISSN 1465-542X, Vol. 15, no 1, R15- p.Article in journal (Refereed) Published
Abstract [en]

Introduction: Experimental evidence suggests a protective role for circulating 25-hydroxyvitamin D (25(OH) D) in breast cancer development, but the results of epidemiological studies have been inconsistent.

Methods: We conducted a case-control study nested within two prospective cohorts, the New York University Women's Health Study and the Northern Sweden Mammary Screening Cohort. Blood samples were collected at enrollment, and women were followed up for breast cancer ascertainment. In total, 1,585 incident breast cancer cases were individually-matched to 2,940 controls. Of these subjects, 678 cases and 1,208 controls contributed two repeat blood samples, at least one year apart. Circulating levels of 25(OH) D were measured, and multivariate odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using conditional logistic regression.

Results: No association was observed between circulating levels of 25(OH) D and overall breast cancer risk (multivariate-adjusted model OR = 0.94, 95% CI = 0.76-1.16 for the highest vs. lowest quintile, ptrend = 0.30). The temporal reliability of 25(OH)D measured in repeat blood samples was high (intraclass correlation coefficients for season-adjusted 25(OH) D > 0.70). An inverse association between 25(OH) D levels and breast cancer risk was observed among women who were = 45 years of age (ORQ5-Q1 = 0.48, 95% CI = 0.30-0.79, ptrend = 0.01) or premenopausal at enrollment (ORQ5-Q1 = 0.67, 95% CI = 0.48-0.92, ptrend = 0.03).

Conclusions: Circulating 25(OH) D levels were not associated with breast cancer risk overall, although we could not exclude the possibility of a protective effect in younger women. Recommendations regarding vitamin D supplementation should be based on considerations other than breast cancer prevention.

Place, publisher, year, edition, pages
2013. Vol. 15, no 1, R15- p.
National Category
Cancer and Oncology
URN: urn:nbn:se:umu:diva-76821DOI: 10.1186/bcr3390ISI: 000320158100024OAI: diva2:636984
Available from: 2013-07-15 Created: 2013-07-15 Last updated: 2015-04-22Bibliographically approved

Open Access in DiVA

fulltext(346 kB)107 downloads
File information
File name FULLTEXT02.pdfFile size 346 kBChecksum SHA-512
Type fulltextMimetype application/pdf

Other links

Publisher's full text

Search in DiVA

By author/editor
Lenner, PerHallmans, Göran
By organisation
OncologyNutritional ResearchDepartment of Biobank Research
In the same journal
Breast Cancer Research
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 107 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 54 hits
ReferencesLink to record
Permanent link

Direct link